GO:0070663 regulation of leukocyte proliferation: Immune Cell Expansion Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070663 (regulation of leukocyte proliferation) describes any process that modulates the frequency, rate or extent of leukocyte proliferation, a central control point in immunity and inflammation.
• Leukocyte proliferation is not a single pathway but an integrated output of cytokine signaling, transcription factor networks, epigenetic remodeling and noncanonical Hippo signaling [4,8].
• Local monocyte proliferation can precede tissue macrophage differentiation, showing that proliferation control operates in defined anatomical niches.
• Dysregulated leukocyte proliferation contributes to hematological malignancies such as acute lymphoblastic leukemia and to chronic inflammatory diseases such as atherosclerosis [2,6].
• Key regulators include FLIP, CK2, Ikaros, IL-12-dependent epigenetic programs, MafB and Hippo pathway components [3,4,6,7,8].
• CRISPR knockout, point-mutation, knock-in and overexpression models enable causal testing of candidate regulators of leukocyte proliferation [4,6].
Description
Regulation of leukocyte proliferation (GO:0070663) is the biological process that controls how frequently, how rapidly and to what extent leukocytes divide. Leukocytes include lymphocytes, monocytes, macrophages, neutrophils and related immune cells, and their expansion must be tightly balanced because insufficient proliferation causes immunodeficiency whereas excessive proliferation drives autoimmunity, chronic inflammation and leukemia [2,6]. The term therefore captures a decision point that integrates extracellular cues, intracellular signaling and epigenetic state [4,8].
regulation of leukocyte proliferation At A Glance
| GO ID | GO:0070663 |
|---|---|
| GO term | regulation of leukocyte proliferation |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Major function | Modulates the frequency, rate or extent of leukocyte proliferation |
| Biological context | Immune cell expansion, inflammation, hematopoiesis and leukemogenesis |
| Representative regulators | FLIP, CK2, Ikaros, IL-12-dependent epigenetic programs, MafB, noncanonical Hippo signaling |
| Disease relevance | Acute lymphoblastic leukemia, atherosclerosis and other inflammatory disorders |
| Research methods | CRISPR KO, point mutation, knock-in, overexpression, flow cytometry, RNA-seq and epigenomic profiling |
What Is GO:0070663?
In practical terms, GO:0070663 covers any molecular or cellular process that modulates the frequency, rate or extent of leukocyte proliferation. It is a biological_process term, meaning it describes a dynamic program rather than a static structure or a single enzymatic activity. The definition is intentionally broad so that cytokine-driven proliferation, antigen-driven clonal expansion, epigenetic licensing of proliferation and negative feedback that restrains division can all be annotated under the same term [4,8].
Why Is regulation of leukocyte proliferation Important in Cell Biology?
Regulation of leukocyte proliferation is important because it determines the size and persistence of immune responses. When this process is too weak, pathogens escape control; when it is too strong or poorly restrained, leukocytes accumulate and damage tissues, as seen in atherosclerotic plaque inflammation and in acute lymphoblastic leukemia [2,6]. Understanding GO:0070663 therefore informs immunology, hematology, oncology and inflammation research, and it provides a rational framework for target discovery and therapeutic intervention [4,6,7,8].
• Controls clonal expansion of lymphocytes during adaptive immune responses.
• Regulates monocyte and macrophage pool size in tissues, including the lung.
• Links cytokine signaling to epigenetic remodeling of proliferating immune cells.
• Contributes to the pathogenesis of acute lymphoblastic leukemia when dysregulated.
• Shapes chronic inflammatory diseases such as atherosclerosis.
• Provides a mechanistic explanation for how noncanonical Hippo signaling restrains or promotes leukocyte function.
• Offers candidate targets for immunomodulatory therapeutics, including agents that affect lymphocyte survival and proliferation [1,7].
• Supports the design of CRISPR screens to identify causal regulators of immune cell expansion [4,6].
• Helps interpret single-cell and functional genomics data in immunology [3,8].
• Connects basic immune cell biology to translational models of autoimmunity, infection and cancer [2,6].
What Happens During regulation of leukocyte proliferation?
Receiving proliferative cues
In simple terms: Immune cells first listen for signals that tell them it is time to divide.
Regulation of leukocyte proliferation begins with extracellular and cell-contact cues that license or block division. Cytokine-dependent signals, including IL-12-dependent programs, can drive T cell proliferation and are coupled to epigenetic changes that make proliferation genes accessible. In parallel, noncanonical Hippo signaling can modulate leukocyte function and proliferation, showing that multiple signaling modules converge on the same decision.
Intracellular signaling integration
In simple terms: Inside the cell, several signaling pathways vote on whether to divide.
Once cues are received, intracellular kinases and adaptor proteins integrate them. Casein kinase II (CK2) and Ikaros are established regulators of cellular proliferation in acute lymphoblastic leukemia, illustrating how kinase activity and transcription factor balance control leukocyte expansion. FLIP also regulates lymphocyte proliferation and death, placing survival and division decisions in the same molecular circuit.
Transcription factor and epigenetic control
In simple terms: The cell changes which genes are open for reading, which locks in a proliferative state.
Proliferation requires transcription factors and chromatin remodelers to establish a permissive state. Epigenetic regulation of IL-12-dependent T cell proliferation demonstrates that chromatin-level control is a core component of GO:0070663. MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation, showing that lineage-specific transcription factors can confine proliferation to a defined developmental window and anatomical site.
Execution of cell division
In simple terms: Finally, the cell commits to division and produces daughter leukocytes.
When the balance of signals favors proliferation, leukocytes enter the cell cycle and divide. This output is the measurable endpoint of GO:0070663 and is commonly assessed by DNA labeling, dilution of proliferation dyes or expansion of antigen-specific populations [3,7]. Because the process is reversible and context-dependent, the same cell type can proliferate in one niche and remain quiescent in another.
Negative feedback and restraint
In simple terms: Brakes are as important as accelerators, because unchecked division causes disease.
Regulation of leukocyte proliferation includes mechanisms that restrain division. Loss of restraint is associated with hematological malignancy, as shown by the role of CK2 and Ikaros in acute lymphoblastic leukemia. Inflammatory contexts such as atherosclerosis also reflect excessive leukocyte activity and accumulation, underscoring the need for negative regulation within GO:0070663.
Key Genes Involved in GO:0070663 regulation of leukocyte proliferation
The following genes and proteins have been experimentally linked to regulation of leukocyte proliferation in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| FLIP (CFLAR) | Regulates lymphocyte proliferation and death | Model for survival-proliferation coupling in lymphocytes |
| CK2 (CSNK2A1/CSNK2A2) | Kinase that promotes cellular proliferation in leukemia | Target for proliferation studies in acute lymphoblastic leukemia |
| IKZF1 (Ikaros) | Transcription factor controlling proliferation in leukemia | Loss-of-function models in ALL research |
| IL12A/IL12B | Cytokines upstream of T cell proliferation | Epigenetic studies of IL-12-dependent T cell expansion |
| MAFB | Transcription factor restricting local monocyte proliferation | Lung interstitial macrophage differentiation models |
| Hippo pathway components (e.g., STK3/STK4, LATS1/2, YAP/TAZ) | Noncanonical signaling that regulates leukocyte function | Functional studies of leukocyte proliferation and activation |
| MRG15 (MORF4L1) | Epigenomic remodeling component in proliferating cells | Studies of Treg-mediated regulation of proliferation |
| TIP60 (KAT5) | Chromatin modifier in proliferation-associated remodeling | Epigenomic remodeling experiments |
| CD4 | Marker of T helper and regulatory T cells | Treg and T cell proliferation assays |
| FOXP3 | Regulatory T cell lineage factor | Treg functional studies |
| CD28 | Costimulatory receptor for T cell activation | T cell proliferation assays |
| IL2 | Growth factor for lymphocyte expansion | Proliferation and survival readouts |
| MYC | Broad regulator of cell cycle entry | Proliferation studies in leukocytes |
| BCL2 | Anti-apoptotic regulator linked to survival | Survival-proliferation balance studies |
| TNFAIP3 (A20) | Negative regulator of NF-kB signaling | Inflammation and proliferation control |
| IL6 | Cytokine that can promote leukocyte expansion | Inflammatory proliferation models |
| CCND1 | Cell cycle regulator | Proliferation assays in leukocytes |
How Is regulation of leukocyte proliferation Regulated?
Regulation of leukocyte proliferation is itself regulated at multiple levels. Cytokine signaling, including IL-12-dependent pathways, controls the epigenetic accessibility of proliferation genes in T cells. Noncanonical Hippo signaling provides an additional layer of control over leukocyte function and proliferation. Transcription factors such as MafB can restrict proliferation to specific developmental windows and tissue niches. In disease settings, kinases such as CK2 and transcription factors such as Ikaros set the threshold for proliferation in leukemic cells. Therapeutics that modulate lymphocyte survival and proliferation, such as telitacicept, illustrate the translational importance of this regulatory network.
regulation of leukocyte proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CSNK2A1 | Acute lymphoblastic leukemia | Knockout or point-mutation leukemia cell lines |
| IKZF1 | Acute lymphoblastic leukemia | Knockout and rescue models in ALL cells |
| MAFB | Lung interstitial macrophage differentiation | Conditional knockout in monocyte/macrophage lineages |
| CFLAR (FLIP) | Lymphocyte proliferation and survival disorders | Overexpression and knockout lymphocyte models |
| IL12A/IL12B | T cell proliferation and inflammatory disease | Epigenetic perturbation and cytokine stimulation assays |
Acute lymphoblastic leukemia
Acute lymphoblastic leukemia is a hematological malignancy in which leukocyte proliferation is dysregulated. CK2 and Ikaros have been shown to regulate cellular proliferation in acute lymphoblastic leukemia, making them central to understanding how GO:0070663 goes awry in leukemia.
Atherosclerosis and chronic inflammation
Inflammation during the life cycle of the atherosclerotic plaque involves leukocyte recruitment, activation and proliferation, and persistent leukocyte activity contributes to plaque progression. Regulation of leukocyte proliferation is therefore relevant to cardiovascular inflammation.
Lung macrophage biology
MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation, demonstrating that proliferation control shapes tissue macrophage populations in the lung. Disruption of this process may alter lung immune homeostasis.
Autoimmune and immune-mediated disease
Therapeutics that modulate lymphocyte survival and proliferation, such as telitacicept, highlight the clinical importance of controlling leukocyte expansion in autoimmune and immune-mediated conditions. FLIP-dependent regulation of lymphocyte proliferation and death further supports this link.
From regulation of leukocyte proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for leukocyte proliferation? | CRISPR knockout in primary leukocytes or leukemic cell lines |
| Does a specific point mutation alter proliferation signaling? | CRISPR point-mutation knock-in [4,6] |
| Does a disease-associated variant change proliferation? | Knock-in of the variant with functional proliferation readouts |
| Where and when is a regulator expressed during proliferation? | Tagged knock-in with imaging or proteomics |
| Does overexpression drive excessive leukocyte expansion? | CRISPR overexpression models |
| Which pathways control leukocyte proliferation genome-wide? | CRISPR library screening with proliferation readouts [4,6] |
How to Study the regulation of leukocyte proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry with dye dilution | Cell division history | Quantifying leukocyte proliferation [3,7] |
| RNA-seq | Transcriptional state | Identifying proliferation-associated gene programs |
| ATAC-seq / ChIP-seq | Chromatin accessibility and factor binding | Epigenetic control of proliferation |
| Phospho-signaling assays | Kinase pathway activity | Testing CK2 and Hippo pathway involvement [4,6] |
| CRISPR knockout | Gene requirement | Causal testing of candidate regulators |
| CRISPR point mutation | Effect of specific residues or variants | Dissecting signaling mechanisms [4,6] |
| CRISPR knock-in tagging | Protein localization and interactions | Tracking regulators during proliferation |
| CRISPR overexpression | Gain-of-function effects | Testing whether a gene drives proliferation |
Flow cytometry and proliferation dyes
Flow cytometry with dye dilution or DNA-labeling dyes is a standard method to measure leukocyte proliferation at the single-cell level. It is used to quantify clonal expansion and to compare proliferation between genotypes [3,7].
Transcriptomics and epigenomics
RNA-seq and epigenomic profiling reveal the transcriptional and chromatin programs that accompany leukocyte proliferation. Epigenetic regulation of IL-12-dependent T cell proliferation was dissected using such approaches.
Signaling and kinase assays
Kinase activity assays and phospho-signaling readouts are used to test whether CK2, Hippo pathway components or other regulators control proliferation. CK2 and Ikaros regulation of proliferation in acute lymphoblastic leukemia exemplifies this approach.
Genetic perturbation and rescue
Knockout, point-mutation and rescue experiments establish causality. FLIP regulation of lymphocyte proliferation and death and MafB-restricted monocyte proliferation were both defined through genetic perturbation studies [3,7].
How CRISPR Can Be Used to Study GO:0070663 regulation of leukocyte proliferation
Knockout
CRISPR knockout is used to delete candidate regulators of leukocyte proliferation and measure the resulting change in division rate. This approach has been applied to genes such as CK2 and Ikaros in acute lymphoblastic leukemia.
Point Mutation
CRISPR point mutation introduces precise amino acid changes to test which residues are required for proliferation signaling. This is valuable for dissecting kinase and transcription factor mechanisms within GO:0070663 [4,6].
Knock-in
Knock-in models can tag endogenous regulators or introduce disease-associated variants. Tagged knock-in enables visualization and proteomic analysis of proteins that control leukocyte proliferation.
Overexpression
CRISPR overexpression tests gain-of-function effects, asking whether increased levels of a regulator are sufficient to drive leukocyte proliferation. This complements loss-of-function studies of FLIP and related molecules.
How EDITGENE Supports regulation of leukocyte proliferation Research
Researchers studying regulation of leukocyte proliferation-related genes often need to determine whether a candidate gene is causally involved in immune cell expansion, and to define the precise residues, variants or expression levels that matter. EDITGENE provides the CRISPR models and screening services required to move from correlation to causation in this field.
Contact EDITGENE today to design your custom CRISPR model for regulation of leukocyte proliferation research.
Frequently Asked Questions About regulation of leukocyte proliferation
What is GO:0070663 regulation of leukocyte proliferation?
GO:0070663 is a Gene Ontology biological_process term defined as any process that modulates the frequency, rate or extent of leukocyte proliferation.
What genes are involved in regulation of leukocyte proliferation?
Genes and proteins linked to this process include FLIP, CK2, Ikaros, IL-12, MafB and noncanonical Hippo pathway components [3,4,6,7,8].
Why is regulation of leukocyte proliferation important in disease?
Dysregulated leukocyte proliferation contributes to acute lymphoblastic leukemia and to chronic inflammatory diseases such as atherosclerosis [2,6].
How is leukocyte proliferation measured in the lab?
Common methods include flow cytometry with proliferation dyes, RNA-seq, epigenomic profiling and genetic perturbation assays [3,7,8].
What role does CK2 play in leukocyte proliferation?
CK2 regulates cellular proliferation in acute lymphoblastic leukemia, making it a key kinase in leukocyte proliferation control.
How does IL-12 affect T cell proliferation?
IL-12-dependent T cell proliferation is regulated at the epigenetic level, linking cytokine signaling to chromatin state.
Can CRISPR be used to study regulation of leukocyte proliferation?
Yes, CRISPR knockout, point mutation, knock-in and overexpression models are widely used to test causal roles of proliferation regulators [4,6,7].
What is the role of MafB in monocyte proliferation?
MafB restricts local monocyte proliferation before lung interstitial macrophage differentiation.
How does noncanonical Hippo signaling affect leukocytes?
Noncanonical Hippo signaling regulates leukocyte function, including proliferation-related outputs.
What services does EDITGENE offer for leukocyte proliferation research?
EDITGENE offers knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening and bioinformatics support [4,6,8].
Conclusion
GO:0070663 regulation of leukocyte proliferation is a central biological process that determines the size and duration of immune responses. Its molecular control involves cytokine signaling, kinases, transcription factors and epigenetic remodeling, and its dysregulation is linked to leukemia and chronic inflammation [2,4,6,7,8]. CRISPR-based models and functional genomics provide the tools needed to dissect this process and to identify therapeutic targets.
References
- 1. Dhillon S. 2021. Telitacicept: First Approval.. Drugs 81(14):1671-1675 PMID: 34463932
- 2. Libby P. 2021. Inflammation during the life cycle of the atherosclerotic plaque.. Cardiovasc Res 117(13):2525-2536 PMID: 34550337
- 3. Vanneste D et al.. 2023. MafB-restricted local monocyte proliferation precedes lung interstitial macrophage differentiation.. Nat Immunol 24(5):827-840 PMID: 36928411
- 4. Kurz ARM et al.. 2018. Noncanonical Hippo Signalling in the Regulation of Leukocyte Function.. Trends Immunol 39(8):656-669 PMID: 29954663
- 5. Hou Y et al.. 2025. CD4(+) Tregs Regulate Heart Growth and Regeneration Through MRG15/TIP60-Mediated Epigenomic Remodeling in Proliferating Cardiomyocytes.. Circulation 152(23):1634-1656 PMID: 41251000
- 6. Gowda C et al.. 2017. Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.. Adv Biol Regul 63:71-80 PMID: 27666503
- 7. Thome M et al.. 2001. Regulation of lymphocyte proliferation and death by FLIP.. Nat Rev Immunol 1(1):50-8 PMID: 11905814
- 8. Schaller M et al.. 2015. Epigenetic regulation of IL-12-dependent T cell proliferation.. J Leukoc Biol 98(4):601-13 PMID: 26059830
